dosing for semaglutide compound Higher dose of increases weight loss, metabolic benefits: Newsroom Troubling Findings in Study of

Turning to another popular GLP-1, Mounjaro (tirzepatide), studies report 20-25% total body weight loss at maximum doses after 72 weeks

GLP-1 agonists reduce albuminuria (protein in the urine, a marker of kidney damage) and appear to slow the progression of diabetic kidney disease

June 20, 2023 For most Americans, the threat of coronavirus has declined dramatically

Do not, under any circumstances, allow anyone else to use your prescription

Our analysis suggests greater efforts are needed to increase access and adherence for patients without type 2 diabetes and those with lower incomes. Reference Rodriguez PJ, Zhang V, Gratzl S, et al

Current Research Status: What Peer-Reviewed Studies Show The key evidence comes from a 2023 NEJM phase 2 trial (Jastreboff et al.)